BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 18796369)

  • 21. MicroRNA in Pancreatic Cancer: From Biology to Therapeutic Potential.
    Rawat M; Kadian K; Gupta Y; Kumar A; Chain PSG; Kovbasnjuk O; Kumar S; Parasher G
    Genes (Basel); 2019 Sep; 10(10):. PubMed ID: 31557962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting KRAS for diagnosis, prognosis, and treatment of pancreatic cancer: Hopes and realities.
    Bournet B; Buscail C; Muscari F; Cordelier P; Buscail L
    Eur J Cancer; 2016 Feb; 54():75-83. PubMed ID: 26735353
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pancreatic cancer: the role of molecular markers in diagnosis and management.
    Lowery MA; O'Reilly EM
    Clin Adv Hematol Oncol; 2011 Dec; 9(12):900-8. PubMed ID: 22252658
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Molecular biology-based diagnosis and therapy for pancreatic cancer].
    Fujita H; Ohuchida K; Mizumoto K; Tanaka M
    Fukuoka Igaku Zasshi; 2011 Jun; 102(6):203-14. PubMed ID: 21823514
    [No Abstract]   [Full Text] [Related]  

  • 25. Personalized therapy for pancreatic cancer: Do we need better targets, arrows, or both?
    O'Hayer KM; Brody JR
    Discov Med; 2016 Feb; 21(114):117-23. PubMed ID: 27011047
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular pathogenesis of pancreatic adenocarcinoma: potential clinical implications.
    Talar-Wojnarowska R; Malecka-Panas E
    Med Sci Monit; 2006 Sep; 12(9):RA186-93. PubMed ID: 16940943
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New Developments in the Molecular Mechanisms of Pancreatic Tumorigenesis.
    Felsenstein M; Hruban RH; Wood LD
    Adv Anat Pathol; 2018 Mar; 25(2):131-142. PubMed ID: 28914620
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pancreatic cancer biology and genetics.
    Bardeesy N; DePinho RA
    Nat Rev Cancer; 2002 Dec; 2(12):897-909. PubMed ID: 12459728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hereditary Pancreatic Cancer Syndromes: Providing Care to At-Risk Families.
    King E; Nehoray BM
    Clin J Oncol Nurs; 2019 Dec; 23(6):579-582. PubMed ID: 31730603
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular landscape of pancreatic cancer: implications for current clinical trials.
    Heestand GM; Kurzrock R
    Oncotarget; 2015 Mar; 6(7):4553-61. PubMed ID: 25714017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Targeted therapies for pancreatic cancer.
    Danovi SA; Wong HH; Lemoine NR
    Br Med Bull; 2008; 87():97-130. PubMed ID: 18753179
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pancreatic carcinoma: conclusive clinical consequences based on molecular biology knowledge for therapy].
    Ketterer K; Friess H; Büchler MW
    Langenbecks Arch Chir Suppl Kongressbd; 1998; 115():405-10. PubMed ID: 9931650
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes.
    McGuigan A; Kelly P; Turkington RC; Jones C; Coleman HG; McCain RS
    World J Gastroenterol; 2018 Nov; 24(43):4846-4861. PubMed ID: 30487695
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Familial pancreatic cancer.
    Jørgensen MT; Mortensen MB; Gerdes AM; De Muckadell OB
    Scand J Gastroenterol; 2008; 43(4):387-97. PubMed ID: 18365902
    [No Abstract]   [Full Text] [Related]  

  • 35. Surveillance for neoplasia in the pancreas.
    Overbeek KA; Cahen DL; Canto MI; Bruno MJ
    Best Pract Res Clin Gastroenterol; 2016 Dec; 30(6):971-986. PubMed ID: 27938791
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetically engineered mouse models of pancreatic cancer: unravelling tumour biology and progressing translational oncology.
    Mazur PK; Siveke JT
    Gut; 2012 Oct; 61(10):1488-500. PubMed ID: 21873467
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Therapeutic advances in pancreatic cancer.
    Paulson AS; Tran Cao HS; Tempero MA; Lowy AM
    Gastroenterology; 2013 Jun; 144(6):1316-26. PubMed ID: 23622141
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular pathobiology of pancreatic adenocarcinoma.
    Mangray S; King TC
    Front Biosci; 1998 Nov; 3():D1148-60. PubMed ID: 9820739
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Available technologies and clinical applications of targeted chemotherapy in pancreatic cancer.
    Mukherjee I; Powell B; Parianos M; Downs D; Ross SB
    Cancer Genet; 2016 Dec; 209(12):582-591. PubMed ID: 27613576
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in the Genetics and Biology of Pancreatic Cancer.
    Aguirre AJ; Collisson EA
    Cancer J; 2017; 23(6):315-320. PubMed ID: 29189326
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.